Healthcare provider profile · identity verified

Praneet Kumar Nanduri, MD

Internal Medicine · SALEM, OR · NPI 1831404367

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	558	85
Gabapentin	Gabapentin	554	153
Amlodipine Besylate	Amlodipine Besylate	508	145
Atorvastatin Calcium	Atorvastatin Calcium	360	114
Levothyroxine Sodium	Levothyroxine Sodium	338	86
Duloxetine Hcl	Duloxetine Hcl	272	82
Pantoprazole Sodium	Pantoprazole Sodium	269	80
Lisinopril	Lisinopril	257	66
Pravastatin Sodium	Pravastatin Sodium	253	72
Metformin Hcl	Metformin Hcl	252	77
Losartan Potassium	Losartan Potassium	232	70
Trazodone Hcl	Trazodone Hcl	227	65
Metoprolol Succinate	Metoprolol Succinate	218	57
Omeprazole	Omeprazole	215	60
Tramadol Hcl	Tramadol Hcl	165	42
Albuterol Sulfate Hfa	Albuterol Sulfate	152	66
Furosemide	Furosemide	152	43
Potassium Chloride	Potassium Chloride	150	39
Eliquis	Apixaban	134	33
Sertraline Hcl	Sertraline Hcl	129	29
Metoprolol Tartrate	Metoprolol Tartrate	126	36
Tamsulosin Hcl	Tamsulosin Hcl	124	34
Ozempic	Semaglutide	113	31
Hydrochlorothiazide	Hydrochlorothiazide	112	33
Buprenorphine	Buprenorphine	107	26
Mirtazapine	Mirtazapine	103	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	101	30
Famotidine	Famotidine	92	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	92	26
Hydralazine Hcl	Hydralazine Hcl	91	28
Fluticasone Propionate	Fluticasone Propionate	86	39
Paroxetine Hcl	Paroxetine Hcl	84	17
Carvedilol	Carvedilol	78	22
Simvastatin	Simvastatin	75	24
Jardiance	Empagliflozin	72	16
Donepezil Hcl	Donepezil Hcl	70	13
Pregabalin	Pregabalin	64	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	21
Memantine Hcl	Memantine Hcl	62	11
Alendronate Sodium	Alendronate Sodium	61	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	19
Rosuvastatin Calcium	Rosuvastatin Calcium	60	25
Tizanidine Hcl	Tizanidine Hcl	59	19
Azelastine Hcl	Azelastine Hcl	58	35
Clopidogrel	Clopidogrel Bisulfate	54	14
Glipizide	Glipizide	53	17
Warfarin Sodium	Warfarin Sodium	53	18
Glipizide Er	Glipizide	52	12
Varenicline Tartrate	Varenicline Tartrate	52	19
Trulicity	Dulaglutide	51	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	43	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	43	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	41	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	11
Xarelto	Rivaroxaban	38	suppressed
Allopurinol	Allopurinol	37	13
Lovastatin	Lovastatin	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Bupropion Hcl	Bupropion Hcl	34	13
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Olanzapine	Olanzapine	32	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	28	suppressed
Prednisone	Prednisone	28	18
Hydrocortisone	Hydrocortisone	27	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Nystatin	Nystatin	26	suppressed
Azithromycin	Azithromycin	25	11
Triamcinolone Acetonide	Triamcinolone Acetonide	25	18
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	21
Mupirocin	Mupirocin	24	17
Buspirone Hcl	Buspirone Hcl	23	suppressed
Cephalexin	Cephalexin	23	16
Nitroglycerin	Nitroglycerin	23	15
Atenolol	Atenolol	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Finasteride	Finasteride	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Alprazolam	Alprazolam	20	suppressed
Digoxin	Digoxin	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Naltrexone Hcl	Naltrexone Hcl	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Montelukast Sodium	Montelukast Sodium	16	suppressed
Sublocade	Buprenorphine	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Lactulose	Lactulose	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Mesalamine	Mesalamine	13	suppressed
Naloxone Hcl	Naloxone Hcl	13	13
Gemfibrozil	Gemfibrozil	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Estradiol	Estradiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error